# Study on the Effect of Famotidine on Pharmacokinetics of Taletrectinib

> **NCT07742384** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Nuvation Bio Inc.** · enrollment: 56 (estimated)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** Taletrectinib
- **DRUG:** Taletrectinib, Famotidine
- **DRUG:** Taletrectinib, Famotidine
- **DRUG:** Taletrectinib
- **DRUG:** Taletrectinib, Famotidine
- **DRUG:** Taletrectinib,Famotidine

## Key facts

- **NCT ID:** NCT07742384
- **Lead sponsor:** Nuvation Bio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-02-02
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07742384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07742384, "Study on the Effect of Famotidine on Pharmacokinetics of Taletrectinib". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07742384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*